A confirmatory trial would be ideal. But from CHMP’s perspective, if the drug is likely to help patients, why not grant conditional approval with a confirmatory trial requirement? It achieves the same goal—making the treatment available while ensuring longer-term validation.
Market Data 
Markets 
AI
